Skip to main content

Does Jardiance cause weight loss?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Sep 28, 2023.

Official Answer by Drugs.com

Key Points

In studies, adult patients taking the 10 mg dose of Jardiance (empagliflozin) had an average weight loss of 2.8% from their baseline weight (their weight at the start of the study). Those receiving the 25 mg tablet had an average weight loss of 3.2% of their baseline weight. The group who received an inactive placebo had a weight loss of 0.4%.

What is Jardiance approved for?

Jardiance is used to help control glucose (blood sugar) in adults and children 10 years of age and older with type 2 diabetes. Jardiance is also FDA-approved to lower the risk of:

Jardiance is an oral tablet taken once-a-day and is used in addition to diet and exercise. Your doctor may adjust your dose so always follow their directions. Only the 10 mg dose is approved for use in chronic kidney disease.

Jardiance can be added to other medicines for type 2 diabetes such as metformin, sulfonylureas, pioglitazone, and insulin. In children, metformin is the only other approved oral medicine for type 2 diabetes.

Jardiance, classified as a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, is manufactured by Boehringer Ingelheim Pharmaceuticals and Eli Lilly.

Will I still lose weight if I take Jardiance with metformin?

Yes, you may achieve weight loss if you are taking metformin in combination with Jardiance. In a 24-week long clinical study with over 600 adults, Jardiance given as add-on therapy to metformin significantly improved weight loss. These patients were not adequately controlled on metformin alone.

Table 1. Weight changes for Jardiance when used with metformin

Jardiance 10 mg + metformin Jardiance 25 mg + metformin Placebo + metformin
Baseline weight 82 kg (180.4 lbs) 82 kg (180.4 lbs) 80 kg (176 lbs)
% change from baseline (mean) -2.5% -2.9% -0.5%
Difference from placebo (mean) -2.0 (95% CI; -2.6, -1.4) -2.5 (95% CI; -3.1, -1.9) n/a

Weight loss was also significant when Jardiance was used with metformin and a sulfonylurea in a study over 24-weeks long.

Related questions

How does Jardiance affect my blood pressure?

Jardiance is not specifically FDA-approved to reduce blood pressure, but a positive effect was seen in clinical trials. Blood pressure was lowered whether Jardiance was used alone (as monotherapy) or with metformin.

Important side effects with Jardiance

Jardiance is usually well-tolerated in patients with type 2 diabetes. However, as with all drugs, there are important side effects you should review with your doctor.

Serious side effects:

In studies in children 10 years and older, the risk of hypoglycemia (low blood sugar) was higher with Jardiance whether or not they used insulin. Otherwise, the safety profile of treated children was similar to that observed in adults with type 2 diabetes.

Common side effects (5% or more of patients):

Bottom Line

This is not all the information you need to know about Jardiance for safe and effective use and does not replace your doctor's advice. Review the full Jardiance information here, and speak to your health care provider if you have questions or concerns before you start treatment.

References
  • Häring HU, Merker L, Seewaldt-Becker E, et al. Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2014;37:1650-1659

  • Tikkanen I, Narko K, Zeller C, et al. Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension. Diabetes Care 2015;38:420-428.

  • Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes 2020. American Diabetes Association. Diabetes Care 2020 Jan; 43(Supplement 1): S98-S110. https://doi.org/10.2337/dc20-S009

  • Jardiance [package insert]. Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield, CT. Revised 6/2023. Accessed June 22, 2023 at https://content.boehringer-ingelheim.com/DAM/7d9c411c-ec33-4f82-886f-af1e011f35bb/jardiance-us-pi.pdf

Read next

Can Jardiance cause kidney problems?

Research suggests it is unlikely for Jardiance to cause acute kidney injury. While uncommon, it is possible for Jardiance (empagliflozin) to cause kidney problems in some people. According to the prescribing information, there have been reports of kidney injury in some people who took Jardiance. Continue reading

How does Jardiance help with heart failure?

Jardiance may help with heart failure by improving your heart’s ability to pump blood throughout the body and deliver oxygen to tissues and organs. It may do this by reducing sodium and fluid retention, improving energy use by the heart, reducing inflammation and preventing or reversing cardiac enlargement. Continue reading

What is Jardiance used for and how does it work?

Jardiance is a sodium-glucose cotransporter-2 (SGLT-2) inhibitor used in addition to diet and exercise to help control blood glucose (sugar) and protect the heart in adults and children 10 years of age and older with type 2 diabetes. It's also approved to help protect the kidney, and lower the risk of cardiovascular death and hospitalizations in adults with chronic kidney disease (CKD). Continue reading

See also:

Related medical questions

Drug information

Related support groups